Mucosal antibody response and SARS‐CoV‐2 shedding in patients with COVID‐19 related olfactory dysfunction
Shilpee Sharma, Sven Saussez(University of Mons), Anaïs Thiriard(Université Libre de Bruxelles), Véronique Olislagers, Arnaud Marchant(Université Libre de Bruxelles), Jérôme R. Lechien(University of Mons), Marie‐Hélène Jurion(Erasmus Hospital), Marie‐Luce Delforge(Université Libre de Bruxelles)
Cited by 1
Related Papers
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
|European Archives of Oto-Rhino-Laryngology|2020|2.8k
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847
Newborns Develop a Th1-Type Immune Response to <i>Mycobacterium bovis</i> Bacillus Calmette-Guerin Vaccination
|The Journal of Immunology|1999|405
Interleukin-10 production during septicaemia
|The Lancet|1994|372
Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review
|Otolaryngology|2019|372